Vitamin B12 Absorption After 40: Why Your Levels Can Fall on a Good Diet

There is a particular kind of frustration that shows up in midlife physicals. You eat well. You have salmon twice a week, eggs most mornings, yogurt in the afternoon. On paper your diet delivers several times the daily requirement of vitamin B12. And yet your labs come back low, or borderline, or "normal" in a way that does not match how you feel.

The explanation is usually not the food. Vitamin B12 absorption after 40 depends on a surprisingly fragile chain of events in the stomach and small intestine, and several links in that chain weaken with age, medication use, and ordinary digestive changes. Intake and absorption are two different problems, and only one of them is solved at the grocery store.

The Nutrient You Eat but Do Not Absorb

B12 is the largest and most structurally complex vitamin in human nutrition, and it is the only one that requires a dedicated transport protein to cross the gut wall. That complexity is the reason it fails so often. Most water-soluble vitamins diffuse across the intestinal lining with minimal ceremony. B12 needs a multi-step handoff involving stomach acid, digestive enzymes, and a protein called intrinsic factor before a single molecule reaches the bloodstream.

A 2022 review of B12 physiology in Vitamins and Hormones laid out how many places this process can break down, from the stomach to the distal ileum, and noted that dietary shortfall is only one cause among many [1]. In older adults, the more common problem is that B12 is present in the meal but never makes it across.

How B12 Absorption Actually Works

Follow a molecule of B12 from a plate of eggs. In the stomach, acid and the enzyme pepsin strip it away from the food proteins it is bound to. Freed, it attaches to a carrier protein called haptocorrin. In the duodenum, pancreatic enzymes degrade haptocorrin and the shift in pH hands B12 over to intrinsic factor, a protein secreted by the same stomach cells that make acid. That intrinsic factor complex travels the length of the small intestine to the distal ileum, where a receptor made of cubilin and amnionless finally pulls it into the body [1].

Four organs, three carrier proteins, one narrow receptor site. Stomach acid is required at the very first step, and intrinsic factor comes from the very cells that produce it. This is why anything that suppresses gastric acid tends to affect B12 twice over.

"Despite its high prevalence in the general population and in the elderly, B12 malabsorption cannot be anymore assessed by the Schilling test, pointing out the urgent need for an equivalent reliable test." [1]

That admission matters. The classic diagnostic test for B12 malabsorption is no longer available, which means clinicians largely infer absorption problems from blood levels and clinical context rather than measuring them directly.

Why Stomach Acid Matters More After 40

Gastric acid output tends to fall with age, often quietly. Chronic atrophic gastritis, which thins the acid-producing lining of the stomach, becomes considerably more common past midlife and frequently produces no digestive symptoms at all. The result is a pattern clinicians call food-cobalamin malabsorption: the person can absorb free, crystalline B12 perfectly well, but cannot release B12 from the protein matrix of actual food.

A widely cited review in the Canadian Medical Association Journal examined B12 deficiency in older patients and identified food-cobalamin malabsorption as the dominant mechanism in that age group, well ahead of classic pernicious anemia or dietary inadequacy [2]. It is an important distinction, because it means a deficiency can develop in someone whose diet would look flawless on a nutrition tracker.

Metformin and Reflux Medication

Two of the most widely prescribed drug classes in adults over 40 both interfere with B12 status, and the evidence is stronger than most people expect.

For metformin, the cleanest data come from a randomized, placebo-controlled trial published in The BMJ. Researchers followed 390 adults with type 2 diabetes for 4.3 years and found that metformin treatment was associated with a mean decrease in B12 concentration of 19 percent compared with placebo, alongside a rise in homocysteine. The absolute risk of outright B12 deficiency was 7.2 percentage points higher in the metformin group, and the authors concluded that regular B12 measurement during long-term metformin treatment should be strongly considered [3].

For acid-suppressing drugs, a case-control study of more than 200,000 people in the Kaiser Permanente system, published in JAMA, compared nearly 26,000 patients with newly diagnosed B12 deficiency against patients without it. Two or more years of proton pump inhibitor use was associated with a 65 percent higher odds of B12 deficiency, and higher daily doses carried stronger associations than lower ones [4]. A separate review of long-term PPI therapy reached a similar conclusion about B12 among other nutrients, noting that the clinical implications accumulate over years rather than weeks [5].

None of this makes these medications the wrong choice. They are prescribed for good reasons, and stopping them on your own is a bad idea. It does mean that years of use quietly shifts the arithmetic of absorption, and that monitoring becomes reasonable rather than paranoid.

The Symptoms That Get Blamed on Age

The early presentation of low B12 is annoyingly nonspecific: persistent fatigue that sleep does not resolve, a slower mental gear, low mood, tingling in the hands or feet, reduced exercise tolerance. Every one of those gets attributed to being busy, being 48, or being stressed.

Because B12 is central to both red blood cell production and the methylation cycle that keeps homocysteine in check, a shortfall shows up in two systems at once. In the BMJ metformin trial, participants who ended the study deficient had a mean homocysteine of 23.7 micromol per liter, compared with 14.9 in participants with normal B12 [3]. Homocysteine is not a symptom you can feel, but it is a useful signal that the methylation machinery is running short on a cofactor.

Neurological symptoms deserve particular respect here. They can appear before anemia does, and the longer they persist, the less reliably they resolve. That is the practical case for catching a B12 problem early rather than waiting for the blood count to change.

The Reserve That Hides the Problem

One reason B12 problems surface slowly is that the liver holds a substantial reserve, typically enough to cover normal requirements for a few years even if absorption stops entirely. That buffer is a genuine advantage biologically and a liability clinically. Absorption can be failing for a long stretch before the blood level drops far enough to trigger a comment from anyone reading the report.

It also explains a pattern that confuses people. Someone starts metformin at 45 and feels fine for years, then at 51 develops fatigue and tingling that seems to come out of nowhere. Nothing came out of nowhere. The reserve was drawing down the whole time, and symptoms arrived when it ran thin. The BMJ metformin trial ran for 4.3 years precisely because shorter studies would have missed the effect [3].

The practical consequence is that timing matters more than most people assume. If you started an acid-reducing medication or metformin several years ago and have never had B12 checked, the absence of a previous problem tells you very little about the present one. Studies suggest that the risk accumulates with duration of exposure rather than appearing suddenly [3][4]. A single measurement today is worth more than a reassuring memory of feeling fine in 2022.

What a "Normal" B12 Result Misses

Serum B12 is the standard test, and it is an imperfect one. It measures total circulating B12, most of which is bound to haptocorrin and unavailable to cells. The fraction bound to transcobalamin, the portion your tissues can actually use, is a minority of the total. This is why people land in the gray zone between 150 and 300 pmol per liter with real symptoms and a technically unremarkable result.

Two functional markers help resolve the ambiguity. Methylmalonic acid rises when B12 is insufficient at the cellular level, and homocysteine rises when methylation slows. If your serum B12 sits in the lower-normal range and you have relevant symptoms, asking about these two markers is a reasonable next step. Context matters as much as the number: a borderline result in someone on metformin and a daily PPI reads very differently from the same number in someone taking neither.

Oral, Sublingual, or Injection

Here the evidence is genuinely nuanced, and it is worth stating plainly. A Cochrane review comparing oral and intramuscular B12 for treating deficiency found that high-dose oral B12 produced comparable improvements in B12 levels in the trials available, though the authors flagged the small number and limited size of those trials [6]. High-dose oral B12 works partly through passive diffusion, a low-efficiency pathway that does not require intrinsic factor.

The practical question is not which route is universally superior, but which one fits the specific failure point. If the obstacle is food-cobalamin malabsorption or years of acid suppression, then free crystalline B12 in any form bypasses the step that failed. If adherence is poor, if the deficiency is symptomatic, or if a clinician wants a predictable rise without depending on a compromised gut, injection removes absorption from the equation entirely. At RenuviaRX, our Vitamin B12 + MIC protocol is prescribed by board-certified physicians for exactly that reason, with the lipotropic components added for patients focused on fat metabolism alongside energy.

Whichever route is chosen, the principle is the same. Studies suggest that correcting the delivery problem, not just the intake, is what moves the numbers. Patients report that the difference is most noticeable when the underlying shortfall was real and longstanding rather than marginal.

Where to Start

If you are over 40, take an inventory rather than a supplement. How long have you been on metformin or an acid-reducing medication? Has anyone checked your B12 in the last two years? Do you have symptoms that you have quietly filed under aging? Those three questions cost nothing and point directly at whether absorption, rather than diet, is the thing to investigate.

Bring the answers to a clinician who will test rather than reassure. A physician-supervised protocol may support restoring levels efficiently when a genuine shortfall is confirmed, and it starts with knowing which link in the chain gave way.

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any new therapy, and do not stop or change a prescribed medication without speaking to the prescribing clinician.

References

1. Guéant JL, Guéant-Rodriguez RM, Alpers DH. Vitamin B12 absorption and malabsorption. Vitamins and Hormones. 2022;119:241-274. doi:10.1016/bs.vh.2022.01.016
2. Andrès E, Loukili NH, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251-259. doi:10.1503/cmaj.1031155
3. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. doi:10.1136/bmj.c2181
4. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. doi:10.1001/jama.2013.280490
5. Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Current Gastroenterology Reports. 2010;12(6):448-457. doi:10.1007/s11894-010-0141-0
6. Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews. 2018;3:CD004655. doi:10.1002/14651858.CD004655.pub3